Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is G  [Clear All Filters]
Rancourt, A., Dufresne, S.S., St-Pierre, G., Lévesque, J.-C., Nakamura, H., Kikuchi, Y., Satoh, M.S., Frenette, J., and Sato, S. (2018). Galectin-3 and N-acetylglucosamine promote myogenesis and improve skeletal muscle function in the mdx model of Duchenne muscular dystrophy.Faseb Jfj201701151RRR.
Mori, Y., Yoshimoto, G., Nishida, R., Sugio, T., Miyawaki, K., Shima, T., Nagasaki, Y., Miyake, N., Harada, Y., Kunisaki, Y., et al. (2018). Gastrointestinal graft-versus-host disease is a risk factor for post-engraftment blood stream infection in allogeneic hematopoietic stem cell transplant recipients.Biol Blood Marrow Transplant.
Chen, H.-J., Huang, R.-L., Liew, P.-L., Su, P.-H., Chen, L.-Y., Weng, Y.-C., Chang, C.-C., Wang, Y.-C., Chan, M.Wing-Yan, and Lai, H.-C. (2018). GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells.Int J Cancer.
Liao, C.-M., Mukherjee, S., Tiyaboonchai, A., Maguire, J.Ann, Cardenas-Diaz, F.L., French, D.L., and Gadue, P. (2018). GATA6 suppression enhances lung specification from human pluripotent stem cells.J Clin Invest.
Mariani, S., Palumbo, G., Cardarelli, L., Santopietro, M., Foà, R., and Giona, F. (2018). Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis?.Acta Haematol139, 240-242.
Song, S., and Lu, Y. (2018). Gene Delivery of Alpha-1-Antitrypsin Using Recombinant Adeno-Associated Virus (rAAV).Methods Mol Biol1826, 183-196.
Ewart, D.T., Peterson, E.J., and Steer, C.J. (2018). Gene editing for inflammatory disorders.Ann Rheum Dis.
Chrispijn, N.D., Andralojc, K.M., Castenmiller, C., and Kamminga, L.M. (2018). Gene expression profile of a selection of Polycomb Group genes during zebrafish embryonic and germ line development.Plos One13, e0200316.
Takahashi, V.K.L., Takiuti, J.T., Jauregui, R., and Tsang, S.H. (2018). Gene therapy in inherited retinal degenerative diseases, a review.Ophthalmic Genet1-9.
Prondzynski, M., Mearini, G., and Carrier, L. (2018). Gene therapy strategies in the treatment of hypertrophic cardiomyopathy.Pflugers Arch.
Muñoz, S.Sanz, Balez, R., Cabral-da-Silva, M.E.Castro, Berg, T., Engel, M., Bax, M., Do-Ha, D., Stevens, C.H., Greenough, M., Bush, A., et al. (2018). Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer's disease PSEN1 A246E patient and a non-demented family member bearing wild-type PSEN1.Stem Cell Res31, 227-230.
Southard, S.M., Kotipatruni, R.P., and Rust, W.L. (2018). Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents.Plos One13, e0203126.
Choi, H.Young, Kim, S.-J., Go, G.Youn, Kwon, A., Im, Y.Sam, Ha, H.-Y., Hong, J.Tae, Jung, J.-W., and Koo, S.Kyung (2018). Generation of a human induced pluripotent stem cell line, KSCBi003-A, from human adipose tissue-derived mesenchymal stem cells using a chromosomal integration-free system.Stem Cell Res31, 1-4.
García-León, J.Antonio, Cabrera-Socorro, A., Eggermont, K., Swijsen, A., Terryn, J., Fazal, R., Nami, F.A., Ordovas, L., Quiles, A., Lluis, F., et al. (2018). Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein tau mutations which displays several phenotypes linked to neurodegeneration.Alzheimers Dement.
Arellano, C.Machuca, Vilches, A., Clemente, E., Pascual-Pascual, S.Ignacio, Bolinches-Amorós, A., Castro, A.Artero, Espinos, C., Rodriguez, M.Leon, Jendelová, P., and Erceg, S. (2018). Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene.Stem Cell Res31, 249-252.
Gagne, A.L., Maguire, J.Ann, Gandre-Babbe, S., Chou, S.T., Tasian, S.K., Loh, M.L., Weiss, M.J., Gadue, P., and French, D.L. (2018). Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL.Stem Cell Res31, 157-160.
Tamo, L., Hibaoui, Y., Kallol, S., Alves, M.P., Albrecht, C., Hostettler, K.E., Feki, A., Rougier, J.-S., Abriel, H., Knudsen, L., et al. (2018). Generation of an alveolar epithelial type II cell line from induced pluripotent stem cells.Am J Physiol Lung Cell Mol Physiol.
Hayer, S.Nicole, Schelling, Y., Hoeflinger, P., Hauser, S., and Schöls, L. (2018). Generation of an induced pluripotent stem cell line from a patient with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): HIHCNi003-A.Stem Cell Res30, 206-209.
Hayer, S.Nicole, Schelling, Y., Huebener-Schmid, J., Weber, J.Jeremiasz, Hauser, S., and Schöls, L. (2018). Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.Stem Cell Res30, 171-174.
Seshadri, N., Sandhu, S., Wu, X., Liu, W., and Ding, H. (2018). Generation of an Rtel1-CreERT2 knock-in mouse model for lineage tracing RTEL1+ stem cells during development.Transgenic Res.
Lee, J., Woo, D.-H., Park, H.-J., Ko, D.Sung, and Kim, J.-H. (2018). Generation of cytochrome P450 polymorphic human induced pluripotent stem cell lines with defective CYP activities.Stem Cell Res31, 117-121.
Kuramoto, Y., Naito, A.T., Tojo, H., Sakai, T., Ito, M., Shibamoto, M., Nakagawa, A., Higo, T., Okada, K., Yamaguchi, T., et al. (2018). Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient.J Mol Cell Cardiol.
Koo, B.-K. (2018). Generation of FLIP and FLIP-FlpE Targeting Vectors for Biallelic Conditional and Reversible Gene Knockouts in Mouse and Human Cells.Methods Mol Biol1842, 255-264.
Amilon, K.R., Cortes-Araya, Y., Moore, B., Lee, S., Lillico, S., Breton, A., Esteves, C.L., and F Donadeu, X. (2018). Generation of Functional Myocytes from Equine Induced Pluripotent Stem Cells.Cell Reprogram.
Lee, S.-Y., Jeong, S.K., Kim, J., and Chung, S.-K. (2018). Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation.Stem Cell Res30, 145-149.